Responses of young energy-restricted sheep to chronically administered insulin-like growth factor I (IGF-I): evidence that IGF-I suppresses the hepatic growth hormone receptor

• Published in: Endocrinology (Philadelphia) Vol. 137; no. 3; pp. 1129 - 1137
• Main Authors: Min, S H, MacKenzie, D D, Breier, B H, McCutcheon, S N, Gluckman, P D
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01-03-1996
• Subjects: Animals; Body composition; Composition effects; Creatinine; Digestibility; Energy Intake; Eosinophils; Factorial design; Growth factors; Growth hormones; Growth rate; Humans; Insulin; Insulin-like growth factor I; Insulin-Like Growth Factor I - administration & dosage; Insulin-Like Growth Factor I - analysis; Insulin-like growth factor II; Insulin-like growth factors; Leukocytes (eosinophilic); Liver; Liver - metabolism; Maintenance; Male; Nutrients; Organ Size; Receptors, Somatotropin - antagonists & inhibitors; Recombinant Proteins - administration & dosage; Salivary gland; Salivary glands; Secretion; Sheep
• ISSN: 0013-7227; 1945-7170
• DOI: 10.1210/endo.137.3.8603584

We have shown previously that chronic administration (8 weeks) of insulin-like growth factor-I (IGF-I) has little growth-promoting effect in well fed sheep. The aim of this study was to investigate the anabolic effects of IGF-I in energy-restricted conditions in which circulating concentrations of IGF-I in control animals were expected to be low. Young castrate male sheep were offered chaffed lucerne at a rate equivalent to 110% maintenance and were treated by sc injection three times per day for either 8 or 12 weeks with recombinant human IGF-I (150 micrograms/kg live wt x day) or saline in a 2 x 2 factorial design (eight animals per cell). IGF-I treatment significantly increased plasma IGF-I concentrations, but reduced plasma concentrations of IGF-II, GH, urea, and creatinine. Treatment with IGF-I also decreased (P < 0.1) GH secretion in response to a GRF load, but significantly (P < 0.05) increased the nonesterified fatty acid response to an epinephrine load. The reduction in circulating GH levels was accompanied by a suppression of [125I]oGH binding to hepatic microsomal membranes. This effect, if apparent in other tissues, may act as a feedback mechanism to limit the local synthesis of IGF-I and could explain why IGF-I treatment had little effect on the growth rate of the sheep, although it did increase nitrogen digestibility of the feed consumed and decreased the fat content of the hind leg. It also differentially promoted the growth of the spleen, thymus, and mandibular salivary gland and increased blood counts of eosinophils. It is concluded that IGF-I does not have marked effects on growth rate or body composition in sheep fed a near-maintenance diet. Possible reasons include the associated suppression of GH secretion and action, which limits the ability of treated animals to repartition absorbed nutrients.